Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
OrganiGram Holdings ( (TSE:OGI) ) has issued an update.
Organigram Global Inc., Canada’s leading cannabis company by market share with extensive cultivation, processing and branded product operations across multiple provinces, will release its first quarter fiscal 2026 results, covering the period ended December 31, 2025, on February 10, 2026, before markets open. The company will host an earnings conference call and webcast the same morning to discuss its performance, with a replay available to investors for 90 days, underscoring Organigram’s ongoing efforts to maintain transparency with the market as it executes on its growth strategy in cannabis and cannabinoid beverages.
The most recent analyst rating on (TSE:OGI) stock is a Hold with a C$2.00 price target. To see the full list of analyst forecasts on OrganiGram Holdings stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
OrganiGram Holdings’ strong revenue growth and market position are offset by profitability challenges and valuation concerns. Technical indicators suggest bullish momentum, but overbought conditions could lead to a pullback. Earnings call insights are positive, but operational challenges remain.
To see Spark’s full report on TSE:OGI stock, click here.
More about OrganiGram Holdings
Organigram Global Inc. is a Canadian cannabis producer listed on the NASDAQ Global Select Market and the TSX, operating through wholly owned subsidiaries including Organigram Inc., a licensed cultivator and processor. The company produces high-quality cannabis for adult-use consumers, participates in both U.S. and Canadian cannabinoid beverages markets via its Collective Project acquisition, and manages a broad portfolio of cannabis brands such as Edison, SHRED, Monjour, Tremblant, Collective Project, BOXHOT and others. Organigram runs cultivation, processing, extraction, edibles manufacturing, packaging and fulfillment facilities across New Brunswick, Quebec, Manitoba and Southwestern Ontario, and is regulated by Health Canada under the Cannabis Act and Cannabis Regulations.
Average Trading Volume: 322,011
Technical Sentiment Signal: Sell
Current Market Cap: C$274.1M
For a thorough assessment of OGI stock, go to TipRanks’ Stock Analysis page.